Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bradley Vince

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Psychiatric Services (Washington, D.C.)|December 12, 2024
Effect of Rurality on Type of Clinicians Delivering Psychotherapy and Prescribing Antidepressants to VeteransLuke Rozema, Sarah L Cornelius, Brian Shiner, et al.
Cancer Chemotherapy and Pharmacology|April 23, 2020
A phase I study of the effect of repeated oral doses of pantoprazole on the pharmacokinetics of a single dose of fedratinib in healthy male subjectsKen Ogasawara, Bradley Vince, Christine Xu, et al.
Suicide & Life-Threatening Behavior|February 12, 2011
Systemic vulnerabilities to suicide among veterans from the Iraq and Afghanistan Conflicts: review of case reports from a National Veterans Affairs DatabasePeter D Mills, Samuel J Huber, Bradley Vince Watts, et al.
The Journal of Nervous and Mental Disease|January 1, 2013
Helping elderly patients to avoid suicide: a review of case reports from a National Veterans Affairs databasePeter D Mills, Bradley Vince Watts, Terri J W Huh, et al.
Pain Medicine (Malden, Mass.)|April 16, 2019
Pharmacokinetics and Abuse Potential of Asalhydromorphone, a Novel Prodrug of Hydromorphone, After Intranasal Administration in Recreational Drug UsersSven Guenther, Travis C Mickle, Andrew C Barrett, et al.
Therapeutic Advances in Drug Safety|May 7, 2019
Abuse potential of mirogabalin in recreational polydrug usersJeanne Mendell, Naama Levy-Cooperman, Ed Sellers, et al.
Journal of Psychopharmacology (Oxford, England)|October 2, 2018
A randomized, double-blind, placebo-controlled, crossover study to evaluate the human abuse liability of solriamfetol, a selective dopamine and norepinephrine reuptake inhibitorLawrence P Carter, Jack E Henningfield, Y Grace Wang, et al.
Alcoholism, Clinical and Experimental Research|July 21, 2020
Interaction of Ethanol and Oral ANS-6637, a Selective ALDH2 Inhibitor in Males: A Randomized, Double-Blind, Placebo-Controlled, Single-Ascending Dose Cohort StudyStephanie S O'Malley, Megan J Shram, Naama Levy-Cooperman, et al.
Advances in Therapy|April 18, 2020
Polyvalent Human Immune Globulin: A Prospective, Open-Label Study Assessing Anti-Hepatitis A Virus (HAV) Antibody Levels, Pharmacokinetics, and Safety in HAV-Seronegative Healthy SubjectsMartin Kankam, Rhonda Griffin, Jeffrey Price, et al.
Journal of Clinical Pharmacology|August 14, 2018
Abuse Potential of Buprenorphine/Samidorphan Combination Compared to Buprenorphine and Placebo: A Phase 1 Randomized Controlled TrialSanjeev Pathak, Bradley Vince, Debra Kelsh, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Psychiatric Services (Washington, D.C.)|December 12, 2024
Effect of Rurality on Type of Clinicians Delivering Psychotherapy and Prescribing Antidepressants to VeteransLuke Rozema, Sarah L Cornelius, Brian Shiner, et al.
Cancer Chemotherapy and Pharmacology|April 23, 2020
A phase I study of the effect of repeated oral doses of pantoprazole on the pharmacokinetics of a single dose of fedratinib in healthy male subjectsKen Ogasawara, Bradley Vince, Christine Xu, et al.
Suicide & Life-Threatening Behavior|February 12, 2011
Systemic vulnerabilities to suicide among veterans from the Iraq and Afghanistan Conflicts: review of case reports from a National Veterans Affairs DatabasePeter D Mills, Samuel J Huber, Bradley Vince Watts, et al.
The Journal of Nervous and Mental Disease|January 1, 2013
Helping elderly patients to avoid suicide: a review of case reports from a National Veterans Affairs databasePeter D Mills, Bradley Vince Watts, Terri J W Huh, et al.
Pain Medicine (Malden, Mass.)|April 16, 2019
Pharmacokinetics and Abuse Potential of Asalhydromorphone, a Novel Prodrug of Hydromorphone, After Intranasal Administration in Recreational Drug UsersSven Guenther, Travis C Mickle, Andrew C Barrett, et al.
Therapeutic Advances in Drug Safety|May 7, 2019
Abuse potential of mirogabalin in recreational polydrug usersJeanne Mendell, Naama Levy-Cooperman, Ed Sellers, et al.
Journal of Psychopharmacology (Oxford, England)|October 2, 2018
A randomized, double-blind, placebo-controlled, crossover study to evaluate the human abuse liability of solriamfetol, a selective dopamine and norepinephrine reuptake inhibitorLawrence P Carter, Jack E Henningfield, Y Grace Wang, et al.
Alcoholism, Clinical and Experimental Research|July 21, 2020
Interaction of Ethanol and Oral ANS-6637, a Selective ALDH2 Inhibitor in Males: A Randomized, Double-Blind, Placebo-Controlled, Single-Ascending Dose Cohort StudyStephanie S O'Malley, Megan J Shram, Naama Levy-Cooperman, et al.
Advances in Therapy|April 18, 2020
Polyvalent Human Immune Globulin: A Prospective, Open-Label Study Assessing Anti-Hepatitis A Virus (HAV) Antibody Levels, Pharmacokinetics, and Safety in HAV-Seronegative Healthy SubjectsMartin Kankam, Rhonda Griffin, Jeffrey Price, et al.
Journal of Clinical Pharmacology|August 14, 2018
Abuse Potential of Buprenorphine/Samidorphan Combination Compared to Buprenorphine and Placebo: A Phase 1 Randomized Controlled TrialSanjeev Pathak, Bradley Vince, Debra Kelsh, et al.
Pageof 2